BAYZF - Roundup Cancer Verdict: Woes Continue For Bayer As It Faces $2.2B Payout | Benzinga
A Pennsylvania jury has ordered Bayer AG’s (OTC:BAYRY) (OTC:BAYZF) Monsanto to pay over $2.2 billion to former Roundup user John McKivison, who attributed his cancer to the popular weedkiller.
The verdict, the largest in the five-year Roundup litigation, includes $250 million for compensatory losses and $2 billion in punitive damages. McKivison, a 49-year-old landscaper, claimed prolonged exposure to Roundup led to his non-Hodgkins lymphoma diagnosis in 2020.
Responding to the verdict, Bayer said, “We disagree with the jury’s adverse verdict that conflicts with the overwhelming weight of scientific evidence and worldwide regulatory and scientific ...